Medical Products Supplies Companies

425 Pontius Avenue North, Suite 200, 98109 Seattle, WA
USA
Telephone +1 650 5204364
http://emulatetx.com

Product Categories

Product categories

01 Electromedical Equipment / Medical Technology
01.11 Other equipment for electromedicine / medical technology

Other equipment for electromedicine / medical technology

THE EMULATE THERAPEUTICS VOYAGER®

Our products

Product category: Other equipment for electromedicine / medical technology
THE EMULATE THERAPEUTICS VOYAGER®
The EMulate Therapeutics Voyager® ulRFE® system is a non-invasive medical device. It is the first of many product expressions of the company’s underlying ulRFE platform technology. Showing promise in pre-clinical and clinical trials, the EMulate Therapeutics Voyager® has potential treatment applications in a wide range of diseases, including cancer, chronic pain, inflammatory, among others. The EMulate Therapeutics Voyager device is being evaluated for the treatment of glioblastoma multiforme (GBM) brain tumors in human clinical trials.

Note: EMulate Therapeutics Voyager ulRFE® system for GBM is an investigational medical device. Limited by Federal United States law to investigational use only.

ad: contact information

About Us

Company details
PIONEERING
Great change can only happen when someone takes the lead and the risk. EMulate Therapeutics is committed to modernizing disease treatment by pioneering groundbreaking medical technology.

RESPONSIBILITY
There is a need for safe, effective and affordable treatments for cancer and other serious diseases. EMulate Therapeutics is taking the responsibility to develop and provide these treatments to patients around the world.

PARTNERSHIP
Developing the best technology means forming a diverse set of partnerships across a broad range of disciplines – including industry and research partners around the world.

LEADERSHIP
The EMulate Therapeutics platform technology is the result of more than a decade of cutting-edge research and development. This dedication and commitment to our mission will help transform the treatment of some of the world’s most serious diseases and address worldwide health and environmental challenges.

ad: company